Jorge DiMartino
Director/Board Member en Gotham Therapeutics Corp. .
Fortuna: 409 820 $ al 31/03/2024
Perfil
Jorge DiMartino is currently a Director at Gotham Therapeutics Corp.
Prior to this, he was the Chief Medical Officer & EVP-Clinical Development at Kronos Bio, Inc. from 2019 to 2024.
Before that, he served as Vice President-Translational Development Oncology at Celgene Corp.
from 2014 to 2019.
He also worked as a Group Medical Director at Genentech, Inc. Additionally, he holds a doctorate degree from both the University of California San Diego and Cornell University Graduate School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
KRONOS BIO INC
0.52% | 04/01/2024 | 315 246 ( 0.52% ) | 409 820 $ | 31/03/2024 |
Cargos activos de Jorge DiMartino
| Empresas | Cargo | Inicio |
|---|---|---|
Gotham Therapeutics Corp.
 Gotham Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Gotham Therapeutics Corp. develops and manufactures pharmaceutical medicines. The firm develops new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. The company was founded by Samie Jaffrey in 2017 and is headquartered in New York, NY. | Director/Board Member | - |
Antiguos cargos conocidos de Jorge DiMartino.
| Empresas | Cargo | Fin |
|---|---|---|
| KRONOS BIO, INC. | Chief Tech/Sci/R&D Officer | 16/02/2024 |
| CELGENE | Corporate Officer/Principal | 01/12/2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - |
Formación de Jorge DiMartino.
| University of California San Diego | Doctorate Degree |
| Cornell University Graduate School | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| KRONOS BIO, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Gotham Therapeutics Corp.
Gotham Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Gotham Therapeutics Corp. develops and manufactures pharmaceutical medicines. The firm develops new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. The company was founded by Samie Jaffrey in 2017 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Jorge DiMartino
